Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 08:00 ET | Source: Upstream Bio, Inc.

Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress

Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress
May 22, 2024 11:15 ET | Source: Upstream Bio, Inc.

Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference

Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024
May 15, 2024 07:00 ET | Source: Upstream Bio, Inc.

Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference

Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference